BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2090 related articles for article (PubMed ID: 15175957)

  • 1. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 23-year experience with malignant renal tumors in infancy and childhood.
    Tröbs RB; Hänsel M; Friedrich T; Bennek J
    Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal neoplasms in children].
    Sawicz-Birkowska K; Czernik J; Bagłaj M; Czauderna P; Kantorowicz-Szymik S; Poznański WA; Mańkowski P; Madziara W; Prokurat A; Osemlak J
    Przegl Lek; 2004; 61 Suppl 2():20-3. PubMed ID: 15686041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIOP treatment guidelines for renal tumours in small infants: fact or fantasy?
    Levie NS; de Kraker J; Bökkerink JP; Appel IM; Aronson DC
    Eur J Surg Oncol; 2000 Sep; 26(6):567-70. PubMed ID: 11034807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary lung metastases in pediatric malignant non-Wilms renal tumors: data from SIOP 93-01/GPOH and SIOP 2001/GPOH.
    Warmann SW; Nourkami N; Frühwald M; Leuschner I; Schenk JP; Fuchs J; Graf N
    Klin Padiatr; 2012 Apr; 224(3):148-52. PubMed ID: 22513793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical aspects in the treatment of patients with unilateral wilms tumor: a report from the SIOP 93-01/German Society of Pediatric Oncology and Hematology.
    Fuchs J; Kienecker K; Furtwängler R; Warmann SW; Bürger D; Thürhoff JW; Hager J; Graf N
    Ann Surg; 2009 Apr; 249(4):666-71. PubMed ID: 19300220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial nephrectomy for unilateral Wilms tumor: results of study SIOP 93-01/GPOH.
    Haecker FM; von Schweinitz D; Harms D; Buerger D; Graf N
    J Urol; 2003 Sep; 170(3):939-42; discussion 943-4. PubMed ID: 12913746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical complications in the treatment of Wilms' tumor.
    Stehr M; Deilmann K; Haas RJ; Dietz HG
    Eur J Pediatr Surg; 2005 Dec; 15(6):414-9. PubMed ID: 16418959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor--single-center experience with renal surgery.
    Seseke F; Zöller G; Ringert RH
    Scand J Urol Nephrol; 2004; 38(5):373-7. PubMed ID: 15764247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study.
    Reinhard H; Aliani S; Ruebe C; Stöckle M; Leuschner I; Graf N
    J Clin Oncol; 2004 Nov; 22(22):4500-6. PubMed ID: 15542800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
    Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
    Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group.
    Furtwängler R; Nourkami N; Alkassar M; von Schweinitz D; Schenk JP; Rübe C; Siemer S; Leuschner I; Graf N
    Klin Padiatr; 2011 May; 223(3):113-9. PubMed ID: 21509706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of advanced Wilms' tumor].
    Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors for perioperative complications in renal surgery for Wilms' tumor].
    Seseke F; Rebmann S; Zöller G; Lakomek M; Ringert RH
    Aktuelle Urol; 2007 Jan; 38(1):46-51. PubMed ID: 17290329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies.
    Reinhard H; Schmidt A; Furtwängler R; Leuschner I; Rübe C; Von Schweinitz D; Zoubek A; Niggli F; Graf N
    Oncol Rep; 2008 Aug; 20(2):463-7. PubMed ID: 18636212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumour: a comparison of surgical aspects in patients with or without pre-operative chemotherapy.
    Safdar CA; Aslam M; Awan SH; Ahmed I; Badshah S
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):521-4. PubMed ID: 16899180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study].
    Ludwig R; Weirich A; Pötter R; Harms D; Bürger D; Michaelis J; Erttmann R; Weinel P; Haas RJ; Ritter J
    Klin Padiatr; 1992; 204(4):204-13. PubMed ID: 1325574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 105.